Mylan Inc (MYL) 56.37 $MYL Business Highlights By The

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mylan Inc (MYL) 56.37 $MYL

Business Highlights
By The Associated Press - AP - Mon Jul 27, 5:12PM CDT
___
AGN: 326.98 (+18.77), QSR: 41.50 (+1.41), F: 14.55 (+0.16), QSR.TO: 54.21 (+2.01), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15), MHFI: 99.59 (-5.99)

Mylan Shares Tank After Teva Pharmaceutical Nixes Takeover Bid
at The Street - Mon Jul 27, 4:47PM CDT
Pharmaceutical giant Mylan (MYL) was the worst performing stock in the S&P 500 on Monday, making it TheStreet's Move of the Day.
AGN: 326.98 (+18.77), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)

After Yesterday's Decline of 14.51%, Mylan Offers Investors Better Value
Comtex SmarTrend(R) - Mon Jul 27, 3:46PM CDT
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $55.40 to a high of $57.58. Yesterday, the shares fell 14.5%, which took the trading range below the 3-day low of $65.46 on volume of 34.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MYL: 56.37 (-9.57)

SmarTrend Watching for Potential Rebound in Shares of Mylan After 14.51% Loss
Comtex SmarTrend(R) - Mon Jul 27, 3:45PM CDT
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $55.40 to a high of $57.58. Yesterday, the shares fell 14.5%, which took the trading range below the 3-day low of $65.46 on volume of 34.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MYL: 56.37 (-9.57)

Analysts expect more tie-ups in generic drug business
AP - Mon Jul 27, 3:43PM CDT
NEW YORK (AP) — Analysts say they expect more tie-ups are coming in the generic drug industry in the wake of Teva's mammoth deal for the generic drug business of Allergan.
1 Comment
IPXL: 49.25 (+0.04), AGN: 326.98 (+18.77), AKRX: 46.16 (+0.77), SGNT: 25.48 (+0.22), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)

Teva and Restaurant Brands are big market movers
AP - Mon Jul 27, 3:25PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
QSR: 41.50 (+1.41), QSR.TO: 54.21 (+2.01), RJET: 3.77 (-4.73), MYL: 56.37 (-9.57), BECN: 32.70 (+2.62), TEVA: 72.00 (+10.15), WAB: 97.93 (+6.59)

Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders
PR Newswire - Mon Jul 27, 2:58PM CDT
Mylan N.V. (NASDAQ: MYL) today announced that it will hold its extraordinary general meeting of shareholders in connection with its proposed acquisition of Perrigo Company plc (NYSE: PRGO; TASE) at the Okura Hotel Amsterdam on Friday, Aug. 28, 2015 at 1 p.m. Central European Time (CET).
PRGO: 193.60 (+7.10), MYL: 56.37 (-9.57)

Is the U.S. Bull Market Starting to Lose Its Luster?
at The Street - Mon Jul 27, 2:04PM CDT
CNBC’s ‘Fast Money’ traders take a closer look at U.S. stocks, as the selloff in China weighs on the market.
BIIB: 309.43 (+9.40), PRGO: 193.60 (+7.10), XOM: 79.26 (-0.68), MYL: 56.37 (-9.57), BMY: 64.30 (-1.68), AGN: 326.98 (+18.77), ISRG: 544.15 (-1.93), SBUX: 56.98 (-0.31), HCA: 92.03 (-0.80), IBM: 159.07 (-0.68), GM: 31.05 (-0.01), TEVA: 72.00 (+10.15), SPLK: 70.60 (-3.31), REGN: 540.03 (-1.82), NVS: 101.54 (-0.26)

3 Health Care Stocks to Trade for Gains
at The Street - Mon Jul 27, 12:56PM CDT
Here's a technical look at how to trade some of the most active stocks on the market right now.
AGN: 326.98 (+18.77), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)

Why Mylan N.V. Stock Slumped Today
George Budwell, The Motley Fool - Motley Fool - Mon Jul 27, 11:11AM CDT
What : Shares of the specialty and generic drugmaker Mylan  fell by more than 14% today on heavy volume after Teva Pharmaceutical Industries Ltd. dropped its $40 billion hostile takeover bid. Instead, Teva has decided to pursue Allergan 's...
MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)

Why Teva Pharmaceutical Industries Ltd. Stock Jumped Today
George Budwell, The Motley Fool - Motley Fool - Mon Jul 27, 10:04AM CDT
What : Shares of the generic drugmaker Teva Pharmaceutical Industries Ltd. rose by 11% in early morning trading after the company announced that it plans on buying Allergan 's generic drug business in a cash and stock deal worth a reported $40.5...
AGN: 326.98 (+18.77), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)

Mylan (MYL) Stock Tanks After Teva Withdraws Takeover Bid
at The Street - Mon Jul 27, 8:55AM CDT
Mylan (MYL) shares are dropping after Teva Pharmaceuticals withdrew its unsolicited $40 billion takeover bid today.
MYL: 56.37 (-9.57)

Teva Confirms Allergan Generics Buy, Drops Mylan Bid
at Investor's Business Daily - Mon Jul 27, 8:10AM CDT
Teva Pharmaceutical (TEVA) confirmed reports Monday that it will buy Allergan's (AGN) generic drugs business for $40.5 billion and dropped its hostile takeover bid for Mylan Pharmaceuticals (MYL). Under the deal, Teva will pay $33.75 billion in cash...
AGN: 326.98 (+18.77), PRGO: 193.60 (+7.10), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)

Downgrade Alert for Mylan (MYL)
Comtex SmarTrend(R) - Mon Jul 27, 8:04AM CDT
Mylan (NASDAQ:MYL) was downgraded from Outperform to Market Perform at Cowen and Company today. The stock closed yesterday at $65.94 on volume of 5.4 million shares, above average daily volume of 5.0 million. In the past 52 weeks, shares of Mylan have traded between a low of $15.49 and a high of $76.68 and closed yesterday at $65.94, which is 326% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.7% while the 50-day MA has declined 0.6%.
MYL: 56.37 (-9.57)

U.S. Stocks On Track For Weak Open As Chinese Stocks Sink
at Investor's Business Daily - Mon Jul 27, 7:59AM CDT
Stocks were on pace for a weak start Monday amid a sell-off in China and more corporate earnings reports. Nasdaq 100 futures slumped 21 points vs. fair value, and S&P 500 futures dropped 7 points. Futures on the Dow Jones industrial average lost 77...
AGN: 326.98 (+18.77), NSC: 82.80 (-0.16), PRGO: 193.60 (+7.10), BIDU: 197.68 (-8.57), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15), MPWR: 47.77 (-0.56), MHFI: 99.59 (-5.99), MSTR: 178.17 (-3.26)

China Tanks as Q2 Marches On - Ahead of Wall Street
Mark Vickery - Zacks Investment Research - Mon Jul 27, 7:50AM CDT
Questions about the sustainability of Chinese government funds' ability to stabilize the market cause a pullback in market support. As a result, the Shanghai index dropped 8.5 percent and the Shenzhen was down 7 percent.
AGN: 326.98 (+18.77), NSC: 82.80 (-0.16), PRE: 134.91 (-0.84), AVB: 168.61 (-0.66), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)


Israel's Teva buys Allergan generic drug company for $40.5B
By DANIEL ESTRIN - AP - Mon Jul 27, 1:14PM CDT
JERUSALEM (AP) — Israel's Teva Pharmaceutical Industries Ltd. said Monday it is purchasing Dublin-based Allergan PLC's generic pharmaceuticals business for $40.5 billion, in what Israeli analysts called the largest-ever acquisition by an Israeli company.
CI: 145.90 (+0.18), AGN: 326.98 (+18.77), ANTM: 151.50 (+0.64), ANTX: 50.28 (+0.03), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15), AET: 110.23 (+0.23), HUM: 183.91 (+2.15)

Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit
PR Newswire - Mon Jul 27, 5:42AM CDT
Mylan N.V. (NASDAQ: MYL) today issued the following statement regarding Teva's (NYSE and TASE: TEVA) announcement of its entry into an agreement to acquire Allergan's Generic Drug Unit and its withdrawal of its unsolicited expression of interest to acquire Mylan.
MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)

European Stocks Sharply Lower as Asian Stocks Drag
at The Street - Mon Jul 27, 5:41AM CDT
European markets opened sharply down as Asian stocks tumbled -- China's Shanghai Composite closed down 8.5%. Gold prices rose and mining stocks recovered from some of last week's losses.
AGN: 326.98 (+18.77), RYAAY: 72.32 (-0.36), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15), UBS: 21.98 (-0.34)

Chinese Stocks Post Biggest One-Day Loss in Eight Years
at The Street - Mon Jul 27, 4:30AM CDT
And four other things you need to know now.
AGN: 326.98 (+18.77), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15), UBS: 21.98 (-0.34), MHFI: 99.59 (-5.99)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Emigrant Partners Boosts Novare Capital with Strategic Investment

Updated Category News Views 420

Emigrant Partners Expands Presence with Novare Capital Investment Emigrant Partners, a leader in the wealth and asset management industry, has recently announced an investment in Novare Capital Management, a prominent independent firm managing $1.8 billion in assets. This strategic partnership is set to empower Novare's growth while reinforcing its mission to serve...

Continue Reading
Investor Insights on Recent Corporate Transactions for PINC, MTSR, ETNB

Updated Category News Views 184

Understanding Recent Corporate Transactions In a significant turn of events for investors, several companies are currently under investigation regarding their corporate actions and potential implications for shareholders. This article delves into the transactions involving Premier, Inc. (NASDAQ: PINC), Metsera, Inc. (NASDAQ: MTSR), and 89bio, Inc. (NASDAQ: ETNB),...

Continue Reading
Innovative Partnership Fuels Advancements in Addiction Treatment

Updated Category News Views 120

Innovative Collaboration in Addiction Treatment Branded Legacy, Inc. (OTC: BLEG) is making strides in public health by forming a revolutionary partnership with McMaster University, an esteemed institution recognized for its influential research in addiction medicine and clinical trials. This strategic alliance involves Branded Legacy's wholly-owned subsidiary, Bio-Legacy...

Continue Reading
Top Bundle IDs for CTV Advertising Revealed by Pixalate

Updated Category News Views 177

Insights on CTV Advertising Rankings Pixalate, a standout leader in ad fraud protection and compliance analytics, has unveiled a comprehensive look at the top 100 Connected TV (CTV) Bundle IDs that dominate global open programmatic ad spend. This research gives a snapshot into how different platforms stack up in terms of ad effectiveness across CTV applications....

Continue Reading
OneMain Holdings Eyes Q2 Results on July 29, 2026

Updated Category News Views 4

OneMain Gears Up for Q2 Insights Mark your calendars, folks, because OneMain Holdings, Inc. (NYSE: OMF) is about to spill the beans on their second quarter 2026 performance on July 29. They're set to unleash their earnings report bright and early that Wednesday, right before the market opens. It's the kind of early bird special any investor keen on understanding the...

Continue Reading